BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:58 PM
Jun 23, 2008
 |  BC Extra  |  Company News

Dyax falls on DX-88 delay

Dyax (NASDAQ:DYAX) fell $0.41 (11%) to $3.35 on Monday after it said the planned closure of its clinical research provider, BattelleCRO Inc., is expected to push back the completion of Dyax's rolling BLA for DX-88 for hereditary angioedema (HAE) to early 4Q08 from mid-year.

Read the full 211 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >